• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中MOZ与核受体共激活因子TIF2的一种新型融合。

A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.

作者信息

Carapeti M, Aguiar R C, Goldman J M, Cross N C

机构信息

Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK.

出版信息

Blood. 1998 May 1;91(9):3127-33.

PMID:9558366
Abstract

Chromosomal abnormalities of band 8p11 are associated with a distinct subtype of acute myeloid leukemia with French-American-British M4/5 morphology and prominent erythrophagocytosis by the blast cells. This subtype is usually associated with the t(8;16)(p11;p13), a translocation that has recently been shown to result in a fusion between the MOZ and CBP genes. We have cloned the inv(8)(p11q13), an abnormality associated with the same leukemia phenotype, and found a novel fusion between MOZ and the nuclear receptor transcriptional coactivator TIF2/GRIP-1/NCoA-2. This gene has not previously been implicated in the pathogenesis of leukemia or other malignancies. MOZ-TIF2 retains the histone acetyltransferase homology domains of both proteins and also the CBP binding domain of TIF2. We speculate that the apparently identical leukemia cell phenotype observed in cases with the t(8;16) and the inv(8) arises by recruitment of CBP by MOZ-TIF2, resulting in modulation of the transcriptional activity of target genes by a mechanism involving abnormal histone acetylation.

摘要

8p11染色体异常与一种具有独特亚型的急性髓系白血病相关,该亚型具有法美英协作组(French-American-British)M4/5形态,且原始细胞有明显的红细胞吞噬现象。这种亚型通常与t(8;16)(p11;p13)相关,最近的研究表明,这种易位会导致MOZ和CBP基因融合。我们克隆了inv(8)(p11q13),这是一种与相同白血病表型相关的异常,并且发现了MOZ与核受体转录共激活因子TIF2/GRIP-1/NCoA-2之间的新型融合。该基因以前未被认为与白血病或其他恶性肿瘤的发病机制有关。MOZ-TIF2保留了两种蛋白质的组蛋白乙酰转移酶同源结构域以及TIF2的CBP结合结构域。我们推测,在t(8;16)和inv(8)病例中观察到的明显相同的白血病细胞表型,是由MOZ-TIF2招募CBP导致的,通过一种涉及异常组蛋白乙酰化的机制,从而调节靶基因的转录活性。

相似文献

1
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.急性髓系白血病中MOZ与核受体共激活因子TIF2的一种新型融合。
Blood. 1998 May 1;91(9):3127-33.
2
Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.伴有inv(8)(p11q13)导致MOZ和TIF2基因融合的急性混合谱系白血病。
Blood. 1998 Sep 15;92(6):2118-22.
3
Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.白血病中8p11染色体带异常:基于MOZ受累情况可区分两种临床综合征。
Blood. 1997 Oct 15;90(8):3130-5.
4
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.MOZ-TIF2诱导的急性髓系白血病需要MOZ核小体结合基序以及TIF2介导的CBP募集。
Cancer Cell. 2003 Mar;3(3):259-71. doi: 10.1016/s1535-6108(03)00051-5.
5
Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13).伴有inv(8)(p11q13)的急性髓系白血病中MOZ和TIF2的一致性融合。
Cancer Genet Cytogenet. 1999 Aug;113(1):70-2. doi: 10.1016/s0165-4608(99)00007-2.
6
RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).对伴有t(8;16)(p11;p13)的急性髓系白血病中MOZ-CBP和CBP-MOZ嵌合转录本的逆转录聚合酶链反应分析
Genes Chromosomes Cancer. 2000 Aug;28(4):415-24. doi: 10.1002/1098-2264(200008)28:4<415::aid-gcc7>3.0.co;2-i.
7
Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).小儿治疗相关骨髓增生异常综合征中MOZ基因重排伴新型染色体易位t(2;8)(p23;p11)
Genes Chromosomes Cancer. 2003 Apr;36(4):413-9. doi: 10.1002/gcc.10172.
8
MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.MOZ-TIF2通过损害CBP功能来抑制核受体和p53的转录。
Mol Cell Biol. 2005 Feb;25(3):988-1002. doi: 10.1128/MCB.25.3.988-1002.2005.
9
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.急性髓系白血病的t(8;16)(p11;p13)易位将一种假定的乙酰转移酶与CREB结合蛋白融合。
Nat Genet. 1996 Sep;14(1):33-41. doi: 10.1038/ng0996-33.
10
A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).一例与急性髓系白血病相关的inv(8)(p11q24),在隐匿性t(8;16)中涉及MOZ和CBP基因。
Genes Chromosomes Cancer. 1999 Oct;26(2):161-5.

引用本文的文献

1
KAT6A chimeras form a self-reinforcing epigenetic module with NURF and MLL/COMPASS to sustain AML.KAT6A嵌合体与NURF和MLL/COMPASS形成一个自我强化的表观遗传模块,以维持急性髓系白血病。
Genome Biol. 2025 Aug 19;26(1):253. doi: 10.1186/s13059-025-03743-y.
2
The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency.小分子抑制剂 WM-1119 可有效靶向 KAT6A 重排的 AML,但不能靶向 KMT2A 重排的 AML,尽管它们具有共同的 KAT6 遗传依赖性。
J Hematol Oncol. 2024 Oct 8;17(1):91. doi: 10.1186/s13045-024-01610-0.
3
A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
MOZ-TIF2 白血病小鼠模型表现出 KAT6 依赖性 H3K23 丙酰化和一组活跃发育基因的过表达。
Proc Natl Acad Sci U S A. 2024 Jun 25;121(26):e2405905121. doi: 10.1073/pnas.2405905121. Epub 2024 Jun 18.
4
p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review).p160核受体共激活因子家族成员及其在罕见融合驱动肿瘤中的作用(综述)
Oncol Lett. 2024 Mar 14;27(5):210. doi: 10.3892/ol.2024.14343. eCollection 2024 May.
5
Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.阿尔茨海默病相关的表观遗传改变:新的治疗靶点。
Mol Neurobiol. 2024 Mar;61(3):1282-1317. doi: 10.1007/s12035-023-03626-y. Epub 2023 Sep 12.
6
HEY1-NCOA2 expression modulates chondrogenic differentiation and induces mesenchymal chondrosarcoma in mice.HEY1-NCOA2 表达调控软骨分化并诱导小鼠间充质软骨肉瘤。
JCI Insight. 2023 May 22;8(10):e160279. doi: 10.1172/jci.insight.160279.
7
The MOZ-BRPF1 acetyltransferase complex in epigenetic crosstalk linked to gene regulation, development, and human diseases.与基因调控、发育及人类疾病相关的表观遗传串扰中的MOZ-BRPF1乙酰转移酶复合物
Front Cell Dev Biol. 2023 Jan 11;10:1115903. doi: 10.3389/fcell.2022.1115903. eCollection 2022.
8
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.组蛋白修饰及其在血液系统恶性肿瘤中的治疗靶点的影响。
Int J Mol Sci. 2022 Nov 7;23(21):13657. doi: 10.3390/ijms232113657.
9
Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.基因组分析鉴定出受 HEY1-NCOA2 融合影响的失调基因和通路,并阐明了间叶性软骨肉瘤的肿瘤发生机制。
J Pathol. 2022 Aug;257(5):579-592. doi: 10.1002/path.5899. Epub 2022 Apr 26.
10
KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.KAT6A 和 ENL 形成一个表观转录控制模块,以驱动关键的白血病发生基因表达程序。
Cancer Discov. 2022 Mar 1;12(3):792-811. doi: 10.1158/2159-8290.CD-20-1459.